Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126022031 | 12602203 | 1 | I | 20160719 | 20160728 | 20160728 | PER | US-PFIZER INC-2016352436 | PFIZER | 0.00 | F | Y | 0.00000 | 20160728 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126022031 | 12602203 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 50 MG, 1X/DAY | Y | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 126022031 | 12602203 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 25 MG, UNK | Y | 21992 | 25 | MG | PROLONGED-RELEASE TABLET | |||||||
| 126022031 | 12602203 | 3 | C | PRIMIDONE. | PRIMIDONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126022031 | 12602203 | 1 | Major depression |
| 126022031 | 12602203 | 2 | Anxiety |
| 126022031 | 12602203 | 3 | Essential tremor |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126022031 | 12602203 | Head discomfort | |
| 126022031 | 12602203 | Headache | |
| 126022031 | 12602203 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |